StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Tempus AI (TEM) and Stemline Therapeutics Collaborate to Implement Tempus Next
February 21, 2025 8:33 AM
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
AI
Corporate News
Next Articles
Stifel Reiterates Hold Rating on Tempus AI Inc (TEM)
February 25, 2025 9:09 AM
JPMorgan Downgrades Tempus AI Inc (TEM) to Neutral
February 25, 2025 5:13 AM
Tempus and Stemline Therapeutics, Inc., A Subsidiary of the Menarini Group, Announce Collaboration to Implement Tempus Next, an AI-Enabled Care Pathway Intelligence Platform to Support Patients with M
February 21, 2025 8:30 AM
